Infectious Diseases

Overview

The aim of the seven groups of this area is to improve the outcomes of patients with infectious diseases. The Epidemiology and Public Health group is mainly focused on the epidemiology and prevention of healthcare acquired infections, transmissible infections and on the new preventive vaccines. The Infectious Diseases group focuses on improving the strategies of clinical problems observed in clinical practice. Microbiology studies mechanisms of resistance to antimicrobials, pathogenicity, taxonomy and epidemiology, and infectious diseases diagnostics.

The CRIPS group focuses on the most prevalent aspects of infections in the intensive care unit (ICU), while SODIR group works in the areas of shock, organ dysfunction and resuscitation.

There is also a group focused on infection in immunocompromised pediatric patients, and a group from the CIBBIM-Nanomedicine interested in the synthesis, characterization and applications of engineered inorganic nanoparticles in the field of medicine.

Publications

108

total

876.949

impact factor

4.665

average impact factor

Group Leader: Pere Soler Palacin

team

group-zoom

zoom

group-download

download

Our group has validated the consolidation of its structure. We led national and international projects on Zika virus infection in children and gene therapy in primary immunodeficiency. Last 2018, we have participated in five clinical trials and fifteen research projects. The group has increased the number of publications, resulting in a mean impact factor of 5.09. In addition to previous recognitions, our unit along with Infectious Diseases and Microbiology departments have obtained CSUR accreditation from Health Ministry in tropical diseases in adult and paediatric patients”. Moreover, we have continued increased our funding obtaining international and national competitive grants such as H2020 and Health Institute Carlos III grants as well as private funding such as Jeffrey Modell Foundation. Finally, our close relationship with the patients’ associations and regional foundations brings a central role to patients and their families in conducting responsible research VP.

25

total

122^.071

impact factor

4^.883

average impact factor

SELECTED ARTICLES

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Mendez-Echevarria A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
PLoS Med. 2018 Jul 11;15(7):e1002591.
DOI: 10.1371/journal.pmed.1002591.
IF: 11, 68
Esteve-Sole A, Sologuren I, Martinez-Saavedra MT, Deya-Martinez A, Oleaga-Quintas C, Martinez-Barricarte , Martin-Nalda A, Juan M, Casanova JL, Rodriguez-Gallego C, Alsina L, Bustamante J
Laboratory evaluation of the IFN-gamma circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Crit Rev Clin Lab Sci. 2018 May;55(3):184-204.
DOI: 10.1080/10408363.2018.1444580
IF: 6, 48
Baumann U, Routes JM, Soler-Palacin P, Jolles S
The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.
Front Immunol. 2018 Aug 8;9:1837.
DOI: 10.3389/fimmu.2018.01837.
IF: 5, 51
Soler-Palacin P, Garcia-Prat M, Martin-Nalda A, Franco-Jarava C, Riviere JG, Plaja A, Bezdan D, Bosio M, Martinez-Gallo M, Ossowski S, Colobran R
LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy.
Front Immunol. 2018 Oct 16;9:2397.
DOI: 10.3389/fimmu.2018.02397.
IF: 5, 51
Rodo C, Suy A, Sulleiro E, Soriano-Arandes A, Anton A, Garcia I, Arevalo S, Vazquez E, Vazquez A, Ory F, Sanchez-Seco MP, Rodrigo C, Pumarola T, Carreras E
In utero negativization of Zika virus in a case with serious Central Nervous System abnormalities.
Clin Microbiol Infect. 2018 May; 24(5):549.e1-549.e3.
DOI: 10.1016/j.cmi.2017.09.022
IF: 5, 39

View all publications